[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

US Neonatal (Preterm) Infant Care Market (2010-2015)

April 2010 | 165 pages | ID: U448CE292A9EN
MarketsandMarkets

US$ 3,955.00 US$ 5,650.00 -30 %
Offer valid until March 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Description

Neonatal (Preterm) infant care forms a significant part of the pediatric healthcare market in the U.S. as Neonatal (Preterm) births are one of the leading causes of infant mortality in the country. One in every eight births in the U.S. are Neonatal (Preterm), and the condition is on an alarming rise due to factors such as induced fertility, labor treatments, poor prenatal care, inappropriate maternal age, obesity, and smoking. Neonatal (Preterm) infant care products (equipment, drugs, and formulae) can thus be life-critical as they provide the respiratory, nutritional, and thermal support necessary for the survival of pre-term babies. The vital role of these products in Neonatal (Preterm) infant care thus forms the major factor driving market growth.

Market Estimates and Forecasts

In addition to market data on the submarkets of the U.S. Neonatal (Preterm) infant care market, each section of the report will identify and analyze the market trends, opportunities, and the factors driving or inhibiting market growth. The report will also draw a competitive landscape, in which it will profile the top 35 market players. The report categorizes the U.S. Neonatal (Preterm) Infant Care market as follows:
  • Neonatal (Preterm) Infant Care Equipment (Diagnosis, therapy, and monitoring)
  • Neonatal (Preterm) Infant Formula (For use in hospitals, after discharge, iron fortified cow’s milk formulas, hydrolyzed whey based formulas, casein hydrolysate formulas, amino acid formulas)
  • Neonatal (Preterm) Infant Care Drugs (Antibiotics, bronchodilators, analgesics, diuretics, vassopressors, hematologic agents)
  • Neonatal (Preterm) Infant Care Services Market (Diagnosis, therapy, and monitoring)

What makes our reports unique?
  • We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
  • We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
  • We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

Comprehensive market analysis for the following sectors:
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered
  • Which are the high-growth segments/cash cows and how is the market segmented in terms of devices, infant formula, drugs, services?
  • What are market estimates and forecasts; which markets are doing well and which are not?
  • Where are the gaps and opportunities; what is driving the market?
  • Which are the key playing fields? Which are the winning edge imperatives?
  • How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.
1 INTRODUCTION

1.1 Key Take Aways
1.2 Report Description
1.3 Market Estimates And Forecasts
1.4 Stakeholders
1.5 Research Methodology

2 SUMMARY

3 MARKET OVERVIEW

3.1 Socioeconomic Impact & Cost Analysis
3.2 Drivers
  3.2.1 Increasing Incidence Of Neonatal (Preterm) Births
    3.2.1.1 Inappropriate maternal age
    3.2.1.2 Induced fertility treatments
    3.2.1.3 Genetic predisposition
    3.2.1.4 Lack of awareness and inadequate prenatal care
    3.2.1.5 Obesity, diabetes, smoking
  3.2.2 Availability Of Low-Cost Equipment
  3.2.3 Government Initiatives
3.3 Restraints & Opportunities
  3.3.1 High Entry Barriers
  3.3.2 Novel Trends In Infant Formulae
  3.3.3 Technology Developments
3.4 Novel Approaches To Neonatal (Preterm) Infant Care
  3.4.1 Developmental Care
  3.4.2 Neonatal Information Systems
3.5 Key Findings

4 NEONATAL (PRETERM) INFANT CARE SERVICES MARKET

4.1 Overview
4.2 Therapy & Monitoring Services
4.3 Diagnosis

5 U.S. NEONATAL (PRETERM) INFANT CARE, PRODUCTS MARKET

5.1 Overview
5.2 Delivery Systems
  5.2.1 Drivers
    5.2.1.1 Integral part of Neonatal (Preterm) babies treatment
    5.2.1.2 Replacement units & price differentiation generating revenues
  5.2.2 Restraints
    5.2.2.1 Lack of technology differentiation
    5.2.2.2 Low priced devices
  5.2.3 Opportunity
    5.2.3.1 Systems addressing pain management
  5.2.4 Feeding Tubes
  5.2.5 Intravenous Lines
  5.2.6 Umbilical Catheter
  5.2.7 Peripherally Inserted Central Catheter Line
5.3 Bili Lights
5.4 Respiratory Assistance Devices
  5.4.1 Drivers
    5.4.1.1 Life saving devices
    5.4.1.2 Large number of babies suffering from respiratory distress syndrome
    5.4.1.3 Changing technologies
  5.4.2 Restraints
    5.4.2.1 Life threatening harmful effects of some devices
    5.4.2.2 Low cost ventilators
    5.4.2.3 Opportunities
      5.4.2.3.1 Software solutions make the device user friendly
      5.4.2.3.2 Home care devices
5.5 Thermal Control Equipments
  5.5.1 Drivers
    5.5.1.1 Life saving porTable and versatile equipment
    5.5.1.2 PorTable and versatile systems
  5.5.2 Restraint
    5.5.2.1 Low cost
  5.5.3 Opportunity
    5.5.3.1 Scope for structural improvements
5.6 Monitoring Devices
  5.6.1 Drivers
    5.6.1.1 Novel IT solutions
    5.6.1.2 Non invasive techniques & point-of-care analyzers
      5.6.1.2.1 Increasing demand for reliable patient data
      5.6.1.2.2 Necessity of the devices in early detection of abnormality
  5.6.2 Restraints
    5.6.2.1 Cost reductions
  5.6.3 Opportunity
    5.6.3.1 Expanded use of microprocessing technology
    5.6.3.2 Lab-on-chip monitoring devices
    5.6.3.3 Nanobarcodes and RFID
5.7 Diagnostic Equipment
  5.7.1 Drivers
    5.7.1.1 Technology advances enhancing consumption
  5.7.2 Restraints
    5.7.2.1 Requires high investments
    5.7.2.2 Inadequate clinical trials of the devices
  5.7.3 Opportunity
    5.7.3.1 Nano enabled devices & integration of nanotech and IT
  5.7.4 Imaging Equipment
5.8 Pre Term Infant Formula
5.9 Changing Trends In The Neonatal (Preterm) Infant Formula Industry
5.10 Neonatal (Preterm) Formulas For Use In Hospitals
5.11 Neonatal (Preterm) Follow-Up Formulas After Discharge
5.12 Drugs

6 COMPETITIVE LANDSCAPE

6.1 Overview

7 GEOGRAPHIC ANALYSIS

7.1 Overview
7.2 Opportunities
7.3 Mississippi
  7.3.1 Quick Facts
  7.3.2 Risk Factor Analysis
7.4 Alabama
  7.4.1 Quick Facts
  7.4.2 Risk Factor Analysis
7.5 District Of Columbia
  7.5.1 Quick Facts
  7.5.2 Risk Factor Analysis
7.6 Louisiana
  7.6.1 Quick Facts
  7.6.2 Risk Factor Analysis
7.7 Kentucky
  7.7.1 Quick Facts
  7.7.2 Risk Factor Analysis
7.8 South Carolina
  7.8.1 Risk Factor Analysis
7.9 Tennessee
  7.9.1 Risk Factor Analysis
7.10 Nevada
  7.10.1 Risk Factor Analysis
7.11 New Mexico
  7.11.1 Risk Factor Analysis
7.12 Georgia
  7.12.1 Risk Factor Analysis
7.13 West Virginia
  7.13.1 Risk Factor Analysis
7.14 Oklahoma
  7.14.1 Risk Factor Analysis
7.15 Florida
  7.15.1 Risk Factor Analysis
7.16 Texas
  7.16.1 Risk Factor Analysis
7.17 Arkansas
  7.17.1 Risk Factor Analysis
7.18 California
  7.18.1 Risk Factor Analysis
7.19 New York
  7.19.1 Risk Factor Analysis
7.20 Ohio
  7.20.1 Risk Factor Analysis
7.21 Illinois
  7.21.1 Risk Factor Analysis
7.22 Pennsylvania
  7.22.1 Risk Factor Analysis

8 PATENT ANALYSIS

8.1 Patent Analysis By Assignee
8.2 Patent Analysis By Products
8.3 Patent Analysis By Equipment

9 COMPANY PROFILES

9.1 Abbott Nutrition
9.2 Analogic Corp
9.3 Atom Medical International Corp.
9.4 Arjohuntleigh
9.5 Carefusion Inc
9.6 CAS Medical Systems Inc
9.7 Children's Hospital Of Philadelphia
9.8 Children's National Medical Center
9.9 Clinical Innovations
9.10 Covidien Ltd.
9.11 Criticare Systems, Inc.
9.12 Draegerwerk AG & Co. KGAA
9.13 Edan Instruments, Inc
9.14 Fisher & Paykel Healthcare Corp.
9.15 Fukuda Denshi Co. LTD.
9.16 GE Healthcare
9.17 Hamilton Medical AG
9.18 KcbiomediX, INC
9.19 Masimo Corp.
9.20 Mead Johnson Nutrition CO
9.21 Medela INC.
9.22 Medix I.C.S.A
9.23 Natus Medical INC.
9.24 Nestle Nutrition
9.25 Newyork-Presbyterian Morgan Stanley Children's Hospital
9.26 Nihon Kohden Corp.
9.27 Nonin Medical Inc.
9.28 Oridion Systems Ltd
9.29 Pediatrix Medical Group
9.30 Phoenix Medical Systems PVT LTD
9.31 Philips Respironics INC
9.32 Spacelabs Medical, INC
9.33 Utah Medical Products, INC.
9.34 Welch Allyn INC.
9.35 Wyeth Nutrition CORP

APPENDIX

PATENTS

LIST OF TABLES

SUMMARY Table U.S. NEONATAL (PRETERM) INFANT CARE MARKET 2007 – 2014 ($MILLIONS)
Table 1 U.S. Neonatal (Preterm) Infant Care Market, By Segment 2007 – 2014 ($millions)
Table 2 U.S. Neonatal (Preterm) Infant Care Services Market, 2007 – 2014 ($Millions)
Table3 U.S. Neonatal (Preterm) Infant Care Equipment Market, By Products 2007 – 2014 ($Millions)
Table4 U.S. Neonatal (Preterm) Infant Care Therapy & Monitoring Equipment Market, 2007 – 2014 ($Millions)
Table5 Premature Diagnostic Devices
Table 6 Thermal Control Devices
Table7 Monitoring Devices
Table 8 Diagnostic Equipment
Table 9 U.S. Neonatal (Preterm) Infant Formula Market, By Products 2007 – 2014 ($Millions)
Table 10 Agreements And Collaborations In The Neonatal (Preterm) Infant Care Market (2007-2009)
Table 11 New Product Launches In The Neonatal (Preterm) Infant Care Market (2007-2009)
Table 12 Mergers And Acquisitions In The Neonatal (Preterm) Infant Care Market (2006-2009)
Table 13 Neonatal (Preterm) Birth Rate In Ethnicities - Mississippi
Table 14 Neonatal (Preterm) Birth Rate In Ethnicities - Alabama
Table 15 Neonatal (Preterm) Birth Rate In Ethnicities - District Of Columbia
Table 16 Neonatal (Preterm) Birth Rate In Ethnicities - Louisiana
Table 17 Neonatal (Preterm) Birth Rate In Ethnicities - Kentucky
Table 18 Neonatal (Preterm) Birth Rate In Ethnicities - South Carolina
Table 19 Neonatal (Preterm) Birth Rate In Ethnicities - Tennessee
Table 20 Neonatal (Preterm) Birth Rate In Ethnicities - Nevada
Table 21 Neonatal (Preterm) Birth Rate In Ethnicities - New Mexico
Table 22 Neonatal (Preterm) Birth Rate In Ethnicities - Georgia
Table 23 Neonatal (Preterm) Birth Rate In Ethnicities - West Virginia
Table 24 Neonatal (Preterm) Birth Rate In Ethnicities - Oklahoma
Table 25 Neonatal (Preterm) Birth Rate In Ethnicities - Florida
Table 26 Neonatal (Preterm) Birth Rate In Ethnicities - Texas
Table 27 Neonatal (Preterm) Birth Rate In Ethnicities - Arkansas
Table 28 Neonatal (Preterm) Birth Rate In Ethnicities - California
Table 29 Neonatal (Preterm) Birth Rate In Ethnicities - New York
Table 30 Neonatal (Preterm) Birth Rate In Ethnicities - Ohio
Table 31 Neonatal (Preterm) Birth Rate In Ethnicities - Illinois
Table 32 Neonatal (Preterm) Birth Rate In Ethnicities - Pennsylvania

LIST OF FIGURES

Figure 1 Current Neonatal (Preterm) Birth Rate In The U.S
Figure 2 Socioeconomic Costs
Figure3 Increasing Rates Neonatal (Preterm) Births In The U.S.
Figure4 Prominent Risk Factors Causing Neonatal (Preterm) Births
Figure5 Developmental Care
Figure 6 Utilization Rates Of Respiratory Assistance Devices In Neonatal (Preterm) Infant Care
Figure7 Technology Trends In The Respiratory Assistance Devices Market
Figure 8 Percent Utilization Rates Of Thermal Control Equipment
Figure 9 Technology Trends In The Monitoring Devices Market
Figure 10 Technology Development In The Diagnostic Equipment Market
Figure 11 Utilization Rates Of Diagnostic Equipment In Neonatal (Preterm) Infant Care
Figure 12 Product Development In Theneonatal (Preterm) Infant Care Market
Figure 13 Product Developments In Medical Devices
Figure 14 New Product Launches
Figure 15 Agreements And Collaborations
Figure 16 Neonatal (Preterm) Birth Rates, By States
Figure 17 Patent Analysis, By Assignee (2000 – 2009)
Figure 18 Patents Analysis, By Products (2000 – 2009)
Figure 19 Patents Analysis, By Equipment (2000 – 2009)
Figure 20 Patent Analysis, By Therapy & Monitoring Equipment (2000 – 2009)


More Publications